We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 687

Inherent Disclosure Supports Priority Claim
  • Foley & Lardner LLP
  • USA
  • September 28 2016

In Yeda Research and Development Co. v. Abbott GmbH and Co., the Federal Circuit invoked the doctrine of inherent disclosure to uphold a priority


Inherent Disclosure Satisfied Written Description
  • Foley & Lardner LLP
  • USA
  • September 21 2016

In Yeda Research and Development Co., Ltd. v. Abbott GMBH & Co. KG, Slip Op. 2015-1662 (Fed. Cir. 2016), the Federal Circuit held that a claim to an


CAFC Says Functional Claim Language Does Not Create Divided Infringement
  • Foley & Lardner LLP
  • USA
  • September 20 2016

In LifeNet Health v. LifeCell Corporation, one of the many issues the Federal Circuit decided was that functional claim language did not create a


Willfulness After Halo: Now What?
  • Foley & Lardner LLP
  • USA
  • September 19 2016

The general consensus is that the Supreme Court’s June decision in Halo Electronics v. Pulse Electronics eased the path to proving willfulness, as


Personalized Medicine: Insights Into Current Legal Issues
  • Foley & Lardner LLP
  • USA
  • September 18 2016

In his January 20, 2015 State of the Union Address, President Obama brought to the nation’s attention the promise of personalized medicine when he


Magistrate Judge Nixes TB Test Kit Claims
  • Foley & Lardner LLP
  • USA
  • September 13 2016

In a "Report and Recommendation on Defendants' Joint Motion To Dismiss," U.S. Magistrate Judge Cabell of the U.S. District Court for the District of


District Court Upholds Eligibility Of Personalized Medicine Method Claims For FANAPT
  • Foley & Lardner LLP
  • USA
  • September 6 2016

In Vanda Pharmaceuticals Inc. v. Roxane Labs., Inc., Judge Stark of the U.S. District Court for the District of Delaware upheld the patent


Estoppel Prevents Second IPR Petition Even When New References Were Missed By First Search
  • Foley & Lardner LLP
  • USA
  • August 30 2016

In a case that appears to be a case of first impression, the PTAB found in its decision denying institution in IPR2016-00781 that a final written


The Evolving Standard for Pleading Direct Patent Infringement
  • Foley & Lardner LLP
  • USA
  • August 25 2016

It has been a little more than half a year since the amendments to the Federal Rules of Civil Procedure abrogated Rule 84 and put an end to the Form


The Brexit and Patent Law: What You Need to Know
  • Foley & Lardner LLP
  • European Union, United Kingdom, USA
  • August 23 2016

Now that some time has passed since the Brexit vote, some of the ways in which the vote is likely to impact British patent law are becoming clearer